Jim Cramer's Mad Money Review

Reporting earnings Tuesday morning before the market opens, Johnson & Johnson (NYSE:JNJ) is expected to announce earnings per share of 1.11. The Short Term PowerRating for JNJ is 6.
Waste Management Industries (NYSE:WMI) will drop its bid for Republic Services (NYSE:RSG) citing the current economic climate. The Short Term PowerRatings for WMI and RSG are 6 and 7 respectively.
Intel (NasdaqGS:INTC) reports quarterly earnings Tuesday afternoon after the market closes. Analysts expect the company to report earnings per share of 0.34. The Short Term PowerRating for INTC is 7.
Abbott Laboratories (NYSE:ABT) announced a $5.5 billion share buyback program on Monday. The Short Term PowerRating for ABT is 6.
Morgan Stanley (NYSE:MS) reported that it had completed an agreement with Mitsubishi UFJ that will provide for a $9 billion stake in the Wall Street firm. The Short Term PowerRating for MS is 8.
Genentech Inc. (NYSE:DNA) reports earnings Tuesday after the close. Analysts are expecting EPS of 0.88. The Short Term PowerRating for DNA is 6.

Labels: ABT, DNA, Genentech Inc., Hot Stocks, INTC, Morgan Stanley, MS, RSG, WMI

Abbott Labs (ABT): Cramer likes this stock because it has great drugs and diagnostics. He also recommended Baxter (BAX), Bard (BCR), and Becton Dickinson (BDX).
Infinera (INFN): Cramer doesn't want to be in this stock because he doesn't like the optical sector.
Southern Copper (PCU): Cramer is bullish on this stock, but he thinks Freeport McMoran (FCX) is better since it's cheap and he thinks it will be taken over soon.
Nordstroms (JWN): Cramer thinks this stock should go up to $36, so he would buy the stock here.
E*Trade (ETFC): Cramer thinks you will get hurt if you try to invest in this stock. He is bearish.
Anthracite Capital (AHR): This is a residential REIT, so Cramer is bearish. He recommended the caller buy Annaly Capital (NLY) instead.
Anadarko Petroleum (APC): Cramer thinks this stock is terrific, along with Apache (APA), Devon (DVN), and XTO (XTO).
Trane (TT): Cramer said he has been looking at this stock and was actually going to recommend it later tonight, but he has second thoughts about it because of its residential construction exposure. He still thinks it is a well run company.
Northern Trust (NTRS): Cramer thinks this and State Street (STT) are the best run financial institutions in the country, so he wants to recommend both of them.

Labels: ABT, AHR, APA, APC, BAX, DVN, ETFC, FCX, INFN, Jim Cramer, JWN, Lightning Round, Mad Money, NLY, PCU, STT, TT NTRS, XTO

Bullish calls:
Consolidated Edison (NYSE: ED - News): 'If you're going to go that route, I'd rather see you do ED.'WellPoint (NYSE: WLP - News)Celgene (NasdaqGS: CELG)Gilead Sciences (NasdaqGS: GILD)Genzyme (NasdaqGS: GENZ)Abbott Labs (NYSE: ABT - News): 'ABT has accelerated growth... because they got the best part of the Guidant deal... because they've got a couple of drugs that I think are still expanding... 'Marshall & Ilsley (NYSE: MI - News): 'I like what they did yesterday, very much... It split off its processing business ... MI is committed to be able to bring out value, even at a time when a lot of regional banks are not to be owned. I salute that management for being probably the only company in that whole industry that I think recognizes that you've got to do more than just play the yield curve, because they haven't done well. That's a good stock.'Dendreon (NasdaqGM: DNDN): 'I think DNDN has now had a major move ... I don't think it's done ... That is a very speculative stock though. It is not for those who want to buy it as a drug company ... Which is why I have not gone out with it on my show.'Starwood Hotels (NYSE: HOT - News): 'Steve Hayer must be a guy that nobody could work with, because, boy, he is an unbelievable turnaround guy... They just left him in the dust. The rumor is that they're going to be for sale. The stock could go to $90 if it's for sale ... I want to own HOT... I think that's a great selection.'
Bearish calls:
DTE Energy (NYSE: DTE - News): 'You're too conservative ... I want more growth than that stock can give you.'Eli Lilly (NYSE: LLY - News): 'This is a tough, tough, tough call, because LLY is very well-run, and it's done unbelievable work in the mental health business. The problem with LLY - and this is a problem I see with much of big pharma - it does not have the growth that I want ... I salute the management, but I don't want to buy the company.'MedImmune (NasdaqGS: MEDI): 'I think they're misguided. I do believe that this company should be sold to other people who can do a better job. They have great drugs. They have not succeeded in marketing them.'
Published by SeekingAlpha

Labels: ABT, DNDN, DTE, ED, GILD, HOT, Jim Cramer, Lightning Round, LLY, Mad Money, MEDI, MI, WLP